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Abstract
Gastric carcinoma remains a common disease worldwide
with a dismal prognosis. Therefore, it represents a very
important health problem. It occurs with a high incidence
in Asia and is one of the leading causes of cancer death
in the world. Although the incidence and mortality of
gastric carcinoma are decreasing in many countries,
gastric cancer still represents the second most frequent
malignancies in the world and the fourth in Europe. The
5-year survival rate of gastric carcinoma is low. The
etiology and pathogenesis are not yet fully known. The
study of gastric cancer is important in clinical medicine
as well as in public health. Over the past 15 years,
integrated research in molecular pathology has clarified
the details of genetic and epigenetic abnormalities of
cancer-related genes in the course of the development
and progression of gastric cancer. Gastric cancer, as
all cancers, is the end result of the interplay of many
risk factors as well as protective factors. Although
epidemiological evidence indicates that environmental
factors play a major role in gastric carcinogenesis, the
role of immunological, genetic, and immunogenetic
factors are thought to contribute to the pathogenesis of
gastric carcinoma. Among the environmental factors,
diet and Helicobacter pylori are more amenable to
intervention aimed at the prevention of gastric cancer.
The aim of the present paper is to review and include
the most recent published evidence to demonstrate that
only a multidisciplinary approach will lead to the
advancement of the pathogenesis and prevention of
gastric cancer. On the immunogenetic research it is clear
that evidence is accumulating to suggest that a genetic
profile favoring the proinflammatory response increases
the risk of gastric carcinoma.
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DISEASE DEFINITION AND CLASSIFICATION
The stomach wall is divided into three major areas: fundus,
corpus, or body, and antrum and it has five layers: the inner
lining (the mucosa) contains glands. Underneath is the
submucosa; then is the layer of muscle; next is the subserosa.
The outer layer is the serosa. Gastric cancers are malignancies
arising in any part of stomach. Most gastric cancers arise in
the antrum, the distal third of the stomach. The predominant
site of gastric cancer occurrence has changed over the last
30 years[1-6]. A large number of tumors involving the proximal
stomach and gastro-esophageal junction have been found.
The lesser curvature of  the stomach is more frequently
involved than the greater curvature.
Several different types of cancer can occur in the
stomach. Adenocarcinoma, which starts in the glandular cells,
is the most common cancer of the digestive tract and
histology accounts for 90-95% of  all gastric malignancies.
It can spread to nearby lymph nodes (LN) and other areas
of the body, such as the liver, pancreas, colon, lung, and
ovaries. Other types of malignancy in the stomach are
sarcoma arising from the cells of the muscle layer, and
more common, lymphoma arising in the B and T cells of
the lamina propria. The latter two types of malignancies
have different prognosis and require different management
than adenocarcinoma.
In this review we will concentrate in adenocarcinoma
of the stomach mainly because other types have rarely been
reported[7,8].
Several classification systems are used for gastric cancer.
Borrmann types, developed by Borrmann in 1923, identify
five different types. This tissue classification of gastric cancer
is characterized by the shape of the tumor on gastric mucosa
and its pervading style in gastric wall.
Lauren developed the DIO system of the histomorp-
hological classification, which assumes two main biological
groups: diffuse gastric cancer (D) and intestinal gastric cancer
(I), and other (O)[9,10]. The former two groups account for
90% of all stomach cancers. The intestinal type is well
differentiated and characterized by polypoid or fungating
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lesions that may ulcerate centrally. Many evidences show
that this type is strongly associated with Helicobacter pylori
(H pylori), and usually arises on a backdrop of chronic
gastritis, gastric atrophy, and intestinal metaplasia[11]. Clinically,
the latter is present with diffuse thickening of the stomach
wall, rather than a discernible mass. A genetic predisposition
is presumed in young patients with a diffuse type of gastric
cancer, in contrast to the intestinal type associated with older
age[12,13]. The intestinal type of adenocarcinoma has a better
prognosis than the diffuse variant, most of which have
spread beyond the confines of the stomach at the time of
diagnosis. As with other cancers, stage is the most important
determinant of  outcome[14].
According to the standard of WHO, the cellular
classification in gastric carcinoma has these subtypes:
papillary adenocarcinoma, tubular adenocarcinoma,
mucinous adenocarcinoma, signet-ring cell carcinoma,
squamous cell carcinoma, adenoacanthoma, undifferentiated
carcinoma, unclassified carcinoma and carcinoid tumor.
The Fifth International Union Against Cancer tumor
node metastasis (UICC TNM) classification, which was
published in 1997, based on the number of metastatic LN,
has proved to be a reliable and objective method as the
principal assessing the extent and severity of disease and
determining the prognosis of  cancer patients[15]. The new
TNM classification not only is an objective, simple and
reproducible system, but also a significant prognostic index
for gastric cancer superior to the old classification. The
new TNM classification represents a prognostic factor
equally powerful to the old classification. Especially, the
new N-classification is superior to the old N-classification
in terms of  the homogeneity of  each N group[16,17].
X-ray examination after taking barium meal may
eventually contribute to detecting delayed gastric emptying
quantitatively and indicates the degree of tumor infiltration.
Similarly and more accurately, spiral CT is of help in the
identification of the gross type, invasion to serous layer
and adjacent organs of gastric cancer in its stage of
progression. The CT scan is also valuable in detecting
metastatic as hepatic, splenic, and abdominal apart from
the involvement of LN near the lesion. Enhanced dynamic
CT scan plays a significant role in the diagnosis of gastric
carcinoma; early enhancing phase scanning is the technique
of choice nowadays for demonstrating tumor lesions.
Sophisticated scanning technique is mandatory in improving
the diagnostic accuracy of gastric carcinoma[18,19].
The ultrasound examination of stomach so far has been
still a difficult technique that requires expertize. It can be
used to observe the infiltration of  the tumor into the lower
layer of the mucous membrane. Endoscopic ultrasonography
is very accurate in assessing the depth of tumor infiltration
and the lymph node metastasis. It also can be used to
determine the progress and prognosis of  gastric carcinoma[20].
DISEASE CHARACTERISTICS
Precancerous lesions of stomach
Six different pathological disorders have been described as
increasing the risk for malignancy in the stomach. The following
processes have been implicated as precancerous lesions.
Chronic atrophic gastritis  There is evidence from animal
model that nitrosamine plays a role in developing malignancy.
Achlorhydria in atrophic gastritis allows bacterial colonization
of the stomach, most extremely in places where overgrowth
may cause nitrate reduction and transform the nitrate, which
exist in many foods to potentially develop carcinogenic
N-nitroso compounds[21]. This occurs more often in antrum
gastritis with intestinal metaplasia and non-typical
proliferation. The course of gastritis is rather long and gastric
cancer is believed to develop slowly over many years. Some
patients present dyspepsia, vague abdominal fullness (after
meal), irregular pain, belching, nausea, and vomiting, but
not specific. Severe cardiac gastritis may produce glossitis
and anemia.
Gastric polyps  Familial adenomatous polyps are associated
with upper gastrointestinal adenomas and adenocarcinoma.
Based on Nakamura’s classification[22,23], hyperplastic polyps
were further classified into the following subtypes: the
foveolar epithelial type, fundic glandular hyperplastic type,
and pyloric glandular hyperplastic type. It was found that
atypical hyperplastic foci usually appear in the foveolar
epithelial subtype, indicating a close relationship to
cancer. This finding suggests that the subclassification of
hyperplastic gastric polyp has a higher practical value in
clinical application[24].
Gastric ulcer  Some gastric cancers are considered to
transform from gastric ulcers, but with a low rate, 1-5% in
China. Cancerous degeneration of ulcer was small and the
epithelial regeneration at the ulcer’s edge and benign fusion
of the muscularis mucosa with the muscularis propria were
very common. The cancerous tissue extending to node
metastasis was rare. Therefore, the cancerous tissue down
to the submucosa was found at the margin but not at the
base of the ulcer. These patients should be thought seriously,
specially if they are more than 45 years old, the symptoms
of gastric ulcer are persistent 1 mo after treatment. These
findings that conform well to Hauser’s criteria blood test
are positive. These results suggest that multiple biopsies
should be taken from the edge of chronic ulcers. The most
distinct feature of malignant ulcer was the lack of cancerous
infiltration and muscular residue in the scar tissue of ulcer
base. The existence of this type of ulcer clinically and
pathomorphologically supports the viewpoint that gastric
cancer ulcer can undergo malignant change[25].
Cancer of gastric remnant  Patients after gastrectomy
have more opportunity to get vicious tumor than normal
people, and the course from remnant stomach to gastric
cancer is nearly 15-30 years. Refluxing of intragastric and
bile after gastrectomy became the base of gastritis.
Furthermore the pH is increased and is beneficial to the
abnormal proliferation of  cell, carcinogen such as nitrite
transfer to nitrosamine. Bile salt, a carcinogen, sometimes
can lead to cancer.
Cholecystitis  It was found that both the content of various
kinds of biliary acid salt and pH value of gastric juice were
much higher in patients with gastric cancer, gastric ulcer,
and chronic atrophic gastritis than in normal controls. Bile
acid salt is known to be harmful to gastric mucosa and the
damage becomes more severe with the increase of bile acid
salt concentration and prolongation of exposure. Therefore,
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our results suggest that the bile acid salt in the gastric juice
is one of the carcinogenic factors[26].
Pernicious anemia  Pernicious anemia can lead to atrophic
gastritis and is well known to be associated with gastric
cancer. Pernicious anemia and autoimmune disease in
general is rare in Chinese patients. There are few reports
of pernicious anemia in Chinese patients and does not play
a significant role as a predisposing cause of gastric cancer
in China[27,28].
Gastric schistosomiasis  Gastric carcinoma has been
found arising from schistosomiasis in the epidemic area of
south China and this chronic inflammation has been linked
to development of gastric cancer in this area of China[29].
Early gastric cancer
The designation early gastric cancer (EGC) refers to a gastric
carcinoma, which does not infiltrate beyond the submucosa.
This definition is not influenced by absence or presence of
metastases or by the diameter of the tumor. The 5-year
survival of  EGC is 90% or more. The diagnosis can regularly
be made if, in the case of persistent vague upper abdominal
complaints, an optimal radiological examination of the
stomach is done. At even the slightest radiological suspicion,
or if complaints persist in spite of negative radiological
findings, gastroscopic examination and multiple-aimed
biopsies should follow. Attention should be focused on the
gastric angular incisure, antrum and lesser curvature to
perform site-directed biopsy. Final diagnosis depended on
the pathological diagnosis of the biopsy material. Pathologic
diagnosis would be correct, provided the biopsy material
was taken from the proper site[30,31].
An investigation from Liaoning Province reported
pathological characteristics of EGC in Chinese patients. The
peak age of the patients was between 50 and 59 years. The
incidence in female before 50 years was higher than that in
male but reverse after this age. The most common site
was in lower part of the stomach. Highly differentiated
carcinomas were more frequently found in those cancer
foci of no larger than 0.5 cm in diameter. More signet ring
cell carcinomas were found. Lymphatic metastasis was more
in type IIc+III and the least in type I. Comparing with the
Japanese cases, it was found that the peak age of EGC
patients in Japanese was 10 years older than that in Chinese
patients and most of the tumor occurred in middle part of
the stomach. Type III and mucinous adenocarcinoma was
hardly found[32].
The recurrence rate was higher in submucosal tumors
than in mucosal tumors, in lymphatic and vascular vessel
invasion-positive cases than in negative cases, in synchronous
multiple gastric cancer than in solitary tumors, in tumors
of 1.5 cm or more in diameter than in tumors of less than
1.5 cm. The rate of hematogenic metastasis to the liver or
lung was 45.5%, and the recurrence in the residual stomach
was 27.3% and in lymph node was 27.3%[33].
Advanced gastric cancer
Because of the elusive nature of gastric disorders, gastric
cancer usually is advanced when symptoms first appear.
There are several characteristic routes by which gastric
carcinoma will progress and metastasize: (1) by extension
and infiltration along the mucosal surface and stomach wall
or lymphatic vessels, (2) via lymphatic or vascular embolism,
probably to regional LN, (3) by direct extension into adjacent
structures such as the pancreas, liver, or esophagus, and (4)
by blood-borne spread. The pattern of metastatic spread
of gastric cancer correlates with the size and the location
of tumor. Lesions of the distal portion of the stomach
usually metastasize to infra-pyloric, inferior gastric, and
celiac LN. Tumors in the proximal portion often metastasize
to pancreatic, pericardial, and gastric LN. With advanced
gastric cancer, involvement of the left supraclavicular nodes
may occur. Distant metastatic sites are the lung, adrenal
glands, bone, liver, pancreas, and peritoneal cavity[34].
Clinical syndromes
In the early stage, GC seldom showed significant symptoms,
some of which are common to other, less serious gastrointestinal
disorders (bloating, gas, and a sense of fullness). Some
degrees of dysplasia occur, appetite loss, heartburn, vague
abdominal fullness, flatus, excessive belching, and breath
odor, mild or severe, were similar as in the presentation of
chronic gastritis or gastric ulcer previously reported. Soon
afterwards the difficulty in swallowing, particularly difficulty
that increases over time, nausea and vomiting, abdominal
pain and weight loss were on the rise. In the late stage some
patients might vomit blood; have blood in the stools or
black stools, tiredness due to anemia, abdominal pain and
weight loss are aggravated, a decline in general health.
As other malignancies, early detection, early diagnosis,
and early treatment remain the key to improve the survival
of patients with resected cancer of the gastric cardia. Why
residual tumor left at the resection edge and the presence
of  tumor thrombi do not influence survival needs to be
further studied.
EPIDEMIOLOGY
The epidemiology of  gastric cancer involves many features,
since there are significant geographical, ethnical, and cultural
factors influencing the prevalence of GC. It is more
frequent in the developing world than in the developed
world, more common in Asia than in Europe, and more in
Latin America than in North America and Africa[35]. Stomach
cancer in China has distinct geographically different
distribution. The morbidity in urban areas is higher than in
rural areas, giving a difference of 1.9 times[36]. According
to an investigation between 1989 and 1999, in Linqu County
of  China, no reduction in GC mortality was observed in
the highest risk population worldwide[37].
The most recent estimates indicate that gastric cancer is
the second most common cancer in the world after lung
cancer. It represents 11% of all cancers in men and 7% of
all cancers in women. In developing countries, lung cancer
ranks first, representing 13% of all cancers and gastric
cancer second (12%). In developed countries gastric cancer
ranks fifth, representing 7% of all cancers, three-fourth of
which occur in Asia. About 80% of the cases diagnosed in
Asia occur in China and Japan. Steady decline in the rates
of  gastric cancer has been observed everywhere in the last
few decades. However, the total number of new cases
diagnosed worldwide is increasing mainly because of
increasing and aging of the population. It was estimated
that there were 700 000 new cases in 1980, 755 000 in
1985, 900 000 in 1990, 1 013 000 in 1995, and 1 000 000
in 2000. This indicates that the impact of gastric cancer in
public health is not decreasing[4].
ETIOLOGY
Gastric cancer, of all cancers, is the end result of the
interplay of many risk factors as well as protective factors.
Genetic and environmental factors are likely to play a role
in the etiology of  the disease. Several factors are suspected
to play a role in gastric carcinogenesis, including the effects
of diet, exogenous chemicals, intragastric synthesis of
carcinogens, genetic factors, infectious agents, and
pathological conditions in the stomach (such as gastritis).
According to Correa, there is evidence from pathology and
epidemiology studies that gastric carcinogenesis develops
with the following sequential stages: chronic gastritis; atrophy;
intestinal metaplasia; and dysplasia. The initial stages of
gastritis and atrophy have been linked to excessive salt intake
and infection with H pylori[38].
Environmental factors and gene polymorphisms involved in
the susceptibility of gastric cancer
Several epidemiological evidences indicate that environmental
factors play an important role in gastric carcinogenesis. The
fact that immigrants exhibit incidence rates similar to those
of their country of origin has led researchers to accept
exogenous influences such as environment and diet. The
investigation from China showed that the risk factors of
gastric cancer were living in high incidence area for a long
period, low economic income, low consumption of fresh
vegetables and fruits and animal protein, high intake of
sweet potato and ink fish and salted meat, eating and drinking
too much at one meal and mental injury, and a family history
of gastric cancer. High intake of grains and low intake of
animal fat and proteins appear to be associated with a
decreased risk. Diets rich in vitamins A and C are associated
with low risk for gastric cancer. Controversy exists over the
role of nitrates found in soil-grown foods, drinking water,
and prepared foods. Because refrigeration and a high intake
of  ascorbic acid inhibit the formation of  nitrates, it is
postulated that the presence of these factors may account
for decreasing gastric cancer. Neither smoking tobacco nor
drinking alcohol has been demonstrated to increase the risk
of gastric carcinoma[32,39-44].
H pylori
Gastric carcinogenesis is a multistep and multifactorial
process beginning with H pylori-associated gastritis in most
cases. H pylori infection, together with other environmental
factors and individual susceptibility, determine the final risk
for the development of gastric cancer. The discovery of
H pylori in the early 1980s has proved a turning point in
understanding the pathogenicity of this malignancy. H pylori
infection is common worldwide and about half of the
human population believed to be infected. But only a small
fraction of infected individuals develop gastric cancer.
Additional factors must be involved in the progression toward
cancer[45,46,50].
H pylori are highly host-adapted bacterial pathogens that
establish a chronic infection in the human stomach and
have no known animal or environmental reservoirs. It shows
a high degree of genetic heterogeneity due to mutations
and frequent recombination. In the past, specific genes have
been identified which are associated with bacterial virulence.
These genes (e.g., vacA, cytotoxin associated gene A (cagA),
and iceA) have been studied individually, and distinct
genotypes have been defined. There is accumulating
evidence that the different genotypes of H pylori show a
particular geographic distribution[51]. H pylori strains containing
the cagA protein are associated with more severe disease
and harbor a 40-kb pathogenicity island (PAI) induce NF-κB
activation and interleukin (IL)-8 secretion in gastric epithelial
cells. H pylori changes the expression of genes encoding
growth factors and cytokine/chemokines and their
receptors, apoptosis proteins, transcription factors, and
metalloprotease-disintegrin proteins, and tissue inhibitors of
metalloproteinases[47].
H pylori stimulate endothelial cells to upregulate adhesion
molecule expression and to increase the production of
neutrophil-recruiting chemokines. The PAI encodes a
bacterial type IV secretory system that secretes and
translocates the cagA protein into host cells, where it
i s  phosphorylated by a host-cell kinase and causes
morphological changes. Innocenti et al., found that several,
but not all, H pylori strains are able to activate endothelial
cells to express the adhesion molecules VCAM-1, ICAM-1,
and E-selectin and to secrete neutrophil-recruiting
chemokines, and therefore contribute to tissue damage and
ulcer formation[48,49]. Among people infected with H pylori,
the virulence of  the infecting strain is a major determinant
which develops disease. Strains producing vacuolating
cytotoxin activity are more commonly isolated from people
with peptic ulcers than without. The gene encoding the toxin,
vacA, varies between strains, especially in its signal sequence
and mid regions. vacA genotype influence cytotoxin activity,
and signal sequence type correlates closely with peptic
ulceration. Infection with strains possessing cagA is more
common among people with peptic ulceration or gastric
adenocarcinoma than without. CagA+ H pylori infection is
more closely associated with gastric cancers and peptic ulcers
than cagA-infection. Because cagA+ infection may be
associated with the development of atrophic gastritis, cagA
infection is believed to be a risk factor for intestinal-type
gastric cancer. But Deguchi et al., reported that cagA
infection is also associated with diffuse-type gastric cancer
in Japan. They also found that all p53 alteration were in
H pylori-positive gastric cancer and their mutations were
more frequent in the cagA group, although the correlation
between p53 mutation and H pylori infection did not reach
statistical significance. p53 abnormality was clinically
correlated with prognostic factors (e.g., tumor size, depth,
lymph node metastasis) of gastric cancer. These findings
indicated that cagA+ H pylori infection might have an
important role in the development of gastric cancer with
p53 mutation[52].
The p53 tumor suppressor gene, located on chromosome
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17p13, is one of the most commonly mutated genes in all
types of human cancer. p53 codon 72, which produces
variant proteins with an arginine (Arg) or proline (Pro),
has been reported to be associated with cancers of the
lung, esophagus, and cervix. Recently, studies in Japan
suggested that the Pro/Pro genotype at p53 codon 72
contributes to susceptibility of diffuse-type gastric cancer
patient with H pylori-CG[53]. The mutation of p53 and
inactivation of  p21WAF1 and p16 play an important role
in carcinogenesis of stomach. However, H pylori infection
was not associated with the abnormal expression of  these
three genes in China[54].
Human Chk1 and Chk2 are DNA damage-activated
protein kinases that function as downstream mediators of
ataxia-telangiectasia mutated, which are involved in G2/M
cell-cycle arrest. A study from Japan found a significant
correlation between the levels of expression of Chk1 and
p53 proteins in gastric carcinomas. Chk2 might be important
in the checkpoint function in human gastric carcinomas
with p53 mutation[56]. Mutations of an oncogene, K-ras,
may be involved in the early stage of carcinogenesis of the
intestinal types. The incidence of K-ras mutations in gastric
cancer is only 10%. However, by histological classifications,
the incidence of K-ras mutation was more frequent in
intestinal types than in diffuse types of gastric adenocarcinoma.
In addition, K-ras mutations in H pylori-associated chronic
gastritis were significantly more frequent in gastric
cancer patients than in cancer-free patients (50% vs 3.7%,
P = 0.037)[57].
No evidence for the involvement of antigastric antibodies
in the stimulation of apoptosis was found. Therefore, host
factors may be at least as important as bacterial factors in
determining gastric mucosal responses to H pylori[55].
Interleukin gene polymorphisms and gastric cancer
The presence of H pylori in gastric antrum is, in most cases,
associated with mucosal inflammatory changes consisting
of infiltration of a large number of polymorphonuclear
and mononuclear phagocytes. H pylori reside in the mucus
layer overlying the epithelium and do not invade epithelial
cells. However, accumulating evidence indicates that gastric
infection with H pylori induces the expression of several
proinflammatory cytokines, including IL-1β, IL-6, IL-8,
IL-18 and TNF-α in gastric mucosa.
IL-1β is a potent proinflammatory cytokine and powerful
inhibitor of gastric acid secretion that is upregulated in
the presence of H pylori and is important in initiating and
amplifying the inflammatory response to this infection.
El-Omar et al., reported that gene polymorphisms in
the interleukin gene family of cytokines (IL-1β-31C,
IL-1β-511T, and IL-1RN*2 alleles) are associated with an
increased risk of both hypochlorhydria, in H pylori negative
infected first-degree relatives of gastric carcinoma[58,59]. A
study from Portugal supported the hypothesis that host
genetic factors that affect IL-1 gene determine why some
individuals infected with H pylori develop gastric cancer
while others do not[60,61]. The polymorphism of promoter
region -31C/T of IL-1β gene and the polymorphism of
IL-1RN genes 1/2 and 2/2 are associated with the
susceptibility of gastric cancer in Chinese. Carrying -31T
allele increases the risk of  gastric cancer. Polymorphism of
IL-1RN and IL-1β gene may be used as indicators of
susceptibility of gastric carcinogenesis[62]. A study from Japan
investigated the polymorphism of  -511 T-to-C located in
the IL-1β gene. According to these authors in view of the
results for the IM or CAG without H pylori group, the
presence of the C allele may also indicate a risk of mucosal
atrophy of the stomach in the Japanese population[63].
Serum levels of IL-8 and nitrogen monoxide (NO) are
correlated with CagA+H pylori strain infection. Combined
detection of serum level of IL-8, NO, and HP-CagA will
contribute to the early diagnosis of precancerous lesion in
the stomach[64]. Secretion of IL-8 by gastric epithelial
cell upon H pylori infection is dependent on activation
of NF-κB[65].
IL-18 is a recently identified cytokine (originally termed
interferon γ-inducing factor) and is related to the IL-1 family
both structurally and functionally. Recently research has
showed that IL-18 was increased in a variety of human
inflammatory conditions, including Crohn’s disease,
rheumatoid arthritis, and tuberculoid leprosy with pleiotropic
immunomodulatory functions. It has been found that
IL-18 mRNA expression was greater in H pylori-positive
than in H pylori-negative patients with normal mucosa. But
mature IL-18 protein and active caspase-1 p20 are present
in mucosa of both H pylori-infected and -uninfected subjects.
The presence of  the mature form of  IL-18 in both normal
and gastric mucosa suggests that gastric IL-18 has an
important role in promoting local production of interferon-N
and cell-mediated responses in the gastric mucosa[47].
H pylori induces the production of tumor necrosis
factor-α (TNF-α), which is closely related to epithelial
injury. TNF-α plays a crucial role in host defense against
infection, but a high concentration of TNF-α may cause
severe pathology. The gene for TNF-α is located within
the class III region of the major histocompatibility complex,
which is a highly polymorphic region. The most common
exchanges are G to A transitions in the TNF-α promoter
at positions -308 (-308A) and -238 (-238A), and these
genetic changes have been reported to influence TNF-α
concentrations. It is possible that increased TNF-α
concentrations, as a result of -308A polymorphism, alter
the immune response, which confers susceptibility to gastric
disease with H pylori-cagA subtype infection[66]. In a study in
Spain, these results suggest that TNF and LTA gene
polymorphisms are related to the development of gastric
and duodenal ulcer and may determine disease outcome in
H pylori infection[67].
Wu et al., have reported that no association was noted
between gastric cancer and the distribution of IL-1 and
TNF-α genotypes in Taiwanese Chinese. Logistic regression
analysis revealed that H pylori infection, cigarette smoking,
and IL-10 genotype are independent risks for gastric cancer
in the Taiwanese. Similar studies should be carried out in
different populations and as Wu et al., have correctly
performed the risk of  genotypes should be adjusted with
confounding environmental risks[68].
Genetic polymorphisms of some metabolizing enzymes
Environmental genotoxic chemical agents arising from the
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diet, smoking, and air pollution are responsible for
carcinogenesis in humans. It is generally accepted that the
majority of carcinogenic chemical do not produce their
biological effects per se, but require metabolic activation
by host enzymes: phase I enzymes including cytochrome
P450 enzyme and phase II enzymes including epoxide
hydroxylase, N-acetyltransferase 2 (NAT2), and glutathione
S-transferase (GSTs). Genetic polymorphisms have been
recently shown in many of these enzymes, indicating that
there are genetic differences among individuals in the ability
to metabolize chemicals. Such genetic polymorphisms may
affect the individual susceptibility to chemical carcinogenesis.
From this point of view, the relationship between the genetic
polymorphisms and carcinogenicity has been extensively
examined to determine which polymorphic enzymes are
highly associated with the susceptibility to cancers. Japanese
researchers suggested that a combination of  GSTM1 and
NAT2 decreases the risk of gastric cancer in Japanese
patients[69]. A population-based case-control study in China
suggested that the GSTP1 genotype seems not to be associated
with the risk of gastric cancer and chronic gastritis in a
high-risk Chinese population[70]. The polymorphic genes of
cytochrome P450, CYP2A6, and CYP2E1 have been implicated
in increased susceptibility to certain malignancies. The
CYP2A6 deletion was associated with gastric adenocarcinoma
among Japanese population[72].
KILLER/death receptor DR5
The KILLER/death receptor DR5 has been identified as a
potent inducer of apoptosis, and mapped to chromosome
8p21-22, showing frequent allelic loss in gastric cancer. As
stated before, the p53-induced apoptosis is an important
biological process to prevent the development of cancer,
and is mediated in part by expression of KILLER/DR5
only in cells with wild-type p53 protein, but not in those
lacking p53 function. A report from Japan suspected that
inactivation of KILLER/DR5 caused by mutations of
KILLER/DR5 may be one of the possible escaping
mechanisms against KILLER/DR5-mediated apoptosis and
that inactivating mutation of KILLER/DR5 may contribute
to the promotion or progression of a subset of gastric
cancers[71]. In Japan, another cancer registry-based study
found that the incidence of gastric cancer was increased up
to 5-fold in male relatives of early-onset prostate cancer
patients. Currently unknown genes might contribute to the
observed link between prostate and gastric cancer[73].
E-cadherin
E-cadherin is a member of the cadherin family of calcium-
dependent cell adhesion molecules. These molecules are
localized in lateral cell-cell contacts of the epithelial cells
and regulate the process of homophilic/homotypic adhesion
between epithelial cells and play a role as a tumor suppressor
gene. E-cadherin associates with α-catenin, β-catenin, and
γ-catenin to form a complex that is essential for cell–cell
communication and cell adhesion. Indeed, abnormal
E-cadherin expression (characterized by loss, reduced, and/or
cytoplasmic expression) has been observed in several
types of carcinoma, and is frequently associated with poor
differentiated/undifferentiated carcinomas and/or invasive
tumors. A co-operative study among Portugal, Germany,
and Belgium reported that E-cadherin inactivation is
significantly related with the diffuse histotype in gastric
carcinoma, not only in “pure” diffuse carcinomas but also
in the diffuse component of mixed tumors, β-catenin
mRNA levels are increased in the vast majority of intestinal-
type gastric cancers and this overexpression is independent
of H pylori infection[74,75].
Trefoil regulation, gp130, and gastric cancer
For a long time it was believed that the stomach and the
intestine respond differently to inflammation. The
immunological system of the stomach appears less fully
developed than the intestine. This in part is due to the fact
that nature has given the stomach a mechanism to protect
itself with the production of hydrochloric acid and therefore
an environment where only special bacteria, such as H pylori
can survive. The intestine on the contrary is full of  bacteria;
however, seemingly ends in unrelated diseases. Inflammatory
bowel disease and gastric cancer share in common an origin
in chronic inflammation. An important and interesting
finding that has arisen from research in mice with a
“knock-in” mutation abrogating the Src-homology tyrosine
phosphatase 2 (SHP2)-Ras-ERK signaling that developed
gastric adenomas by 3 mo of age. Mice with a mutation
eliminating the STAT1/3 signaling gp130 (Delta STAT))
showed impaired colonic mucosal wound healing[76]. As stated
in an editorial in Nature Medicine[77], given the close interplay
between the immune response and epithelial cells, it is not
surprising that perturbations in signaling of immune system
mediators play a key role in disease of the gut. It is the
gp130 receptor, which binds the IL-6 family (IL-6 and
IL-11) of  cytokines that serve as an inflammation intersection
between the stomach and the intestine. The homodimers
of  gp130, a transmembrane receptor β-chain, contain two
discrete functional modules which signal through SHP-2/Erk
and STAT1/3 that are responsible for the different behavior
exhibited by the stomach and the intestine in response to
inflammation. To understand the pathogenesis, it is necessary
to understand the function of other family of genes called
the trefoil factor (TFF) family that intimately appear to
work with the gp130 molecule. Suemori et al.[78], discovered
in 1991 a group of small proteins designated intestinal trefoil
factor. These authors demonstrated that it is primarily
expressed and secreted onto the intestinal surface by goblet
cells, suggesting that it may be an important component of
intrinsic mechanisms for defending mucosal integrity.
They are upregulated around areas of epithelial damage,
ulceration, and neoplasia[79].
IL-1 and IL-6 overexpression in chronic gastritis may
lead to mucosal damage and gastric carcinogenesis through
transcriptional repression of TFF1 and TFF2[80]. TFF1
knockout mice developed multiple gastric adenomas and
carcinomas, suggesting that TFF1 is a gastric-specific tumor-
suppressor gene[81]. The gp130 directly regulates the TFF
genes. The trefoils are key downstream targets of the
SHP2/Erk and STAT signaling pathways. The data also
add to TFF1’s credibility as a gastric-specific tumor-suppressor
gene and TFF3’s as a mediator of intestinal homeostasis.
The hyperproliferative lesions was observed in the stomachs
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of  gp130 arise as a result of  enhanced STAT3 activity in
the absence of a counter-acting signal from the SHP2-Ras-
Erk pathway rather than from the complete absence of
(IL-6 and IL-11-mediated) gp130 signaling. IL-6 is likely to
have an important role in the initial phase of intestinal
wound healing. Furthermore, endogenous IL-11, unlike
pharmacologically administered IL-11, seemed to have
negligible effects on the intestinal epithelium.
In conclusion, although the incidence of gastric cancer
is decreasing in some parts of the world, it still takes a
significant toll among the inhabitants of Japan, China, Chile,
Finland, Poland, Austria, Yugoslavia, and Costa Rica. The
key to prevention of cancer of stomach lies in dietary intake.
It is important to consume a balanced diet high in fresh
fruits and vegetables and moderate amount of animal
protein and fats. Salted, smoked, and pickled foods should
be consumed in low quantities.
Screening and early detection programs are very useful.
If  detected at an early stage and treated aggressively,
gastric cancer can be cured. As with all other forms of
gastrointestinal cancers, gastric cancer is insidious in its onset
and development. It usually infiltrates rapidly and can be
disseminated throughout the body before overt signs of
cancer are manifested. Overall 5-year survival rates are
reported to range from about 8% to 16%. Gastric cancer
mimics several other gastrointestinal maladies and diseases
such as polyps, ulcers, dyspepsia, and gastritis. Some of the
most difficult aspects of prevention and early detection are
informing and motivating people at risk for the development
of gastric cancer to seek medical attention for chronic
“stomach problems”. Inappropriate use of home remedies,
self-medication, and misdiagnosis are major hurdles to
overcome.
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